Noetik achieves first milestone in landmark collaboration with GSK
anshulkundaje · x · 2026-08-26
AI biotech company Noetik announced achieving the first near-term milestone in its landmark collaboration with GSK. Earlier this year, Noetik delivered and deployed OCTO-VC model inference and fine-tuning capabilities, meeting GSK's testing criteria. By simulating gene expression, cell states, and tumor-immune interactions, the models allow researchers to generate data for hypothesis exploration, accelerating learning cycles.
More from Companies & People
- Strategy in the AI Era: Focus on 'What Won't Change' — brucemacv · 2026-08-26
- AI Lab Professor Tip: Make Your PhD Inquiry Email Easy to Answer — prof_kamilov · 2026-08-26
- Professor warns: Do not use GenAI for drafting PhD application emails — nandofioretto · 2026-08-26
- Employee used personal ChatGPT with client data: Is this common? — Business_Roof786 · 2026-08-26
- Hugging Face exploring sale: Impact on open models? — shoeshineboy_99 · 2026-08-26
- WSJ: Leopold's hedge fund lost 67% in July due to high leverage on AI bets — rohanpaul_ai · 2026-08-26